198 related articles for article (PubMed ID: 32872307)
1. Increased Cytotoxic Efficacy of Protocatechuic Acid in A549 Human Lung Cancer Delivered via Hydrophobically Modified-Chitosan Nanoparticles As an Anticancer Modality.
Yee Kuen C; Galen T; Fakurazi S; Othman SS; Masarudin MJ
Polymers (Basel); 2020 Aug; 12(9):. PubMed ID: 32872307
[TBL] [Abstract][Full Text] [Related]
2. Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems.
Kuen CY; Fakurazi S; Othman SS; Masarudin MJ
Nanomaterials (Basel); 2017 Nov; 7(11):. PubMed ID: 29117121
[TBL] [Abstract][Full Text] [Related]
3. Increased ROS Scavenging and Antioxidant Efficiency of Chlorogenic Acid Compound Delivered via a Chitosan Nanoparticulate System for Efficient In Vitro Visualization and Accumulation in Human Renal Adenocarcinoma Cells.
Kavi Rajan R; Hussein MZ; Fakurazi S; Yusoff K; Masarudin MJ
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547100
[TBL] [Abstract][Full Text] [Related]
4. Increased radical scavenging activity of thymoquinone and l-ascorbic acid dual encapsulated in palmitoyl-chitosan nanoparticles in a human normal lung fibroblast, MRC-5 due to synergistic antioxidative effects.
Othman N; Md Jamil SNA; Masarudin MJ; Jusoh RABM; Alamassi MN
RSC Adv; 2023 Sep; 13(40):27965-27983. PubMed ID: 37736560
[TBL] [Abstract][Full Text] [Related]
5. In vitro cellular localization and efficient accumulation of fluorescently tagged biomaterials from monodispersed chitosan nanoparticles for elucidation of controlled release pathways for drug delivery systems.
Hassan UA; Hussein MZ; Alitheen NB; Yahya Ariff SA; Masarudin MJ
Int J Nanomedicine; 2018; 13():5075-5095. PubMed ID: 30233174
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Chitosan Nanoparticles Loaded with Protocatechuic Acid (PCA) for the Resistance of
Pham TT; Nguyen TH; Thi TV; Nguyen TT; Le TD; Vo DMH; Nguyen DH; Nguyen CK; Nguyen DC; Nguyen TT; Bach LG
Polymers (Basel); 2019 Jan; 11(1):. PubMed ID: 30960161
[TBL] [Abstract][Full Text] [Related]
7. Long-term anti-inflammatory effects of injectable celecoxib nanoparticle hydrogels for Achilles tendon regeneration.
Kim J; Seo BB; Hong KH; Kim SE; Kim YM; Song SC
Acta Biomater; 2022 May; 144():183-194. PubMed ID: 35331938
[TBL] [Abstract][Full Text] [Related]
8. Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design.
Petkar KC; Chavhan S; Kunda N; Saleem I; Somavarapu S; Taylor KMG; Sawant KK
AAPS PharmSciTech; 2018 May; 19(4):1758-1772. PubMed ID: 29589222
[TBL] [Abstract][Full Text] [Related]
9. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
Huang WT; Larsson M; Lee YC; Liu DM; Chiou GY
Eur J Pharm Biopharm; 2016 Dec; 109():165-173. PubMed ID: 27793756
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Intracellular Delivery of Curcumin by Chitosan-Lipoic Acid as Reduction-Responsive Nanoparticles.
Rezaei S; Kashanian S; Bahrami Y; Zhaleh H; Cruz LJ
Curr Pharm Biotechnol; 2021; 22(5):622-635. PubMed ID: 32720599
[TBL] [Abstract][Full Text] [Related]
11. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
12. Design of Lamivudine Loaded Nanoparticles for Oral Application by Nano Spray Drying Method: A New Approach to use an Antiretroviral Drug for Lung Cancer Treatment.
Öztürk AA; Namlı İ; Güleç K; Görgülü Ş
Comb Chem High Throughput Screen; 2020; 23(10):1064-1079. PubMed ID: 32209039
[TBL] [Abstract][Full Text] [Related]
13. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
14. Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicin.
Masarudin MJ; Cutts SM; Evison BJ; Phillips DR; Pigram PJ
Nanotechnol Sci Appl; 2015; 8():67-80. PubMed ID: 26715842
[TBL] [Abstract][Full Text] [Related]
15. Dual Drugs Anticancer Nanoformulation using Graphene Oxide-PEG as Nanocarrier for Protocatechuic Acid and Chlorogenic Acid.
Bullo S; Buskaran K; Baby R; Dorniani D; Fakurazi S; Hussein MZ
Pharm Res; 2019 Apr; 36(6):91. PubMed ID: 31020429
[TBL] [Abstract][Full Text] [Related]
16. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
Almutairi FM; Abd-Rabou AA; Mohamed MS
Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
18. Nanofabrication of methylglyoxal with chitosan biopolymer: a potential tool for enhancement of its anticancer effect.
Pal A; Talukdar D; Roy A; Ray S; Mallick A; Mandal C; Ray M
Int J Nanomedicine; 2015; 10():3499-518. PubMed ID: 25999714
[TBL] [Abstract][Full Text] [Related]
19. Potential use of gold-silver core-shell nanoparticles derived from
Lee KX; Shameli K; Nagao Y; Yew YP; Teow SY; Moeini H
Front Mol Biosci; 2022; 9():997471. PubMed ID: 36304924
[TBL] [Abstract][Full Text] [Related]
20. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).
Parvathaneni V; Kulkarni NS; Chauhan G; Shukla SK; Elbatanony R; Patel B; Kunda NK; Muth A; Gupta V
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111139. PubMed ID: 32600728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
